These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30997045)

  • 1. Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis.
    Lin E; Vincent FB; Sahhar J; Ngian GS; Kandane-Rathnayake R; Mende R; Morand EF; Lang T; Harris J
    Clin Transl Immunology; 2019; 8(4):e1045. PubMed ID: 30997045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.
    Zhang YJ; Zhang Q; Yang GJ; Tao JH; Wu GC; Huang XL; Duan Y; Li XP; Ye DQ; Wang J
    Z Rheumatol; 2018 Mar; 77(2):151-159. PubMed ID: 27644954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
    Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
    Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
    Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
    Takahashi T; Takahashi T; Ikawa T; Terui H; Takahashi T; Segawa Y; Sumida H; Yoshizaki A; Sato S; Asano Y
    J Dermatol; 2024 Apr; ():. PubMed ID: 38619119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
    Fukayama M; Yoshizaki A; Fukasawa T; Ebata S; Kuzumi A; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
    J Dermatol; 2020 Nov; 47(11):1287-1292. PubMed ID: 32686186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
    Seki N; Tsujimoto H; Tanemura S; Ishigaki S; Takei H; Sugahara K; Yoshimoto K; Akiyama M; Kaneko Y; Chiba K; Takeuchi T
    Cytokine; 2024 Apr; 176():156534. PubMed ID: 38354516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of interleukin-1α in patients with systemic sclerosis.
    Maekawa T; Jinnin M; Ohtsuki M; Ihn H
    J Dermatol; 2013 Feb; 40(2):98-101. PubMed ID: 23078215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis.
    Pellicano C; Miglionico M; Romaggioli L; Colalillo A; Vantaggio L; Napodano C; Callà C; Gulli F; Marino M; Basile U; Rosato E
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
    Sato S; Hasegawa M; Takehara K
    J Dermatol Sci; 2001 Oct; 27(2):140-6. PubMed ID: 11532378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis.
    Birnhuber A; Crnkovic S; Biasin V; Marsh LM; Odler B; Sahu-Osen A; Stacher-Priehse E; Brcic L; Schneider F; Cikes N; Ghanim B; Klepetko W; Graninger W; Allanore Y; Eferl R; Olschewski A; Olschewski H; Kwapiszewska G
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31320452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA-Sequencing Analysis in Patients With Systemic Sclerosis.
    Roberson EDO; Carns M; Cao L; Aren K; Goldberg IA; Morales-Heil DJ; Korman BD; Atkinson JP; Varga J
    Arthritis Rheumatol; 2023 Jan; 75(1):108-119. PubMed ID: 35762854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
    Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
    Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
    Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
    Hasegawa M; Sato S; Takehara K
    Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
    Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
    Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.